Reaction profile

The FDA adverse-event record for nt - endocardiosis

Name: NT - endocardiosis - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

46 FDA reports name nt - endocardiosis, a lower-volume reaction in the CVM extract (VeDDRA 2308). Plate stamps and neighbourhood peers follow.

#1785 of 2,481
by report volume (all reactions): 46
reports citing this reaction: 97.8%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. NT - endocardiosis has 46 reports now versus 46 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: −0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to NT - endocardiosis changes

FDA AER · VeDDRA plate

Code 2308 VOL-TRACE

VOL-TRACE · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 46 reports
DEATH-HOT 97.8%
MID-PACK #1785/2481
PHOTO-FINISH Barbering
SPECIES-DOG Dog · 43
DRUG-LEAD Fluralaner Chew T… · 12
DESK-WIDE 20 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Barbering (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around NT - endocardiosis

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around NT - endocardiosis

NT - endocardiosis: high death-coded share in the FDA AER plate

Signature read: NT - endocardiosis's 97.8% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 46 named reports in the openFDA extract. Death-coded share is upper-third: 45 of 46 reports (97.8% of named reports). Nearest volume peer: Barbering (±0 reports). Lead species Dog (43). Lead co-reported drug Fluralaner Chew Tablets (12).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 43

Other Birds 2

Cat 1

Breeds Most Affected

Crossbred Canine/dog 4

Maltese 4

Retriever - Labrador 4

Dachshund (unspecified) 3

Shepherd Dog - German 2

Chihuahua 2

Other Birds (other) 2

Shih Tzu 2

Shepherd Dog - Australian 2

Akita 1

Associated Drugs

Fluralaner Chew Tablets 12

Milbemycin Oxime + Spinosad 8

Pimobendan 3

Meloxicam 3

Spinosad 2

Famotidine 2

Clavamox 2

Afoxolaner 2

Deracoxib 2

Iv Fluids 2

Tramadol 2

Ivermectin + Pyrantel As Pamoate Salt 2

Enrofloxacin 2

Moxidectin 2

Trilostane 2

Clindamycin 2

Hydrocodone 1

Milbemycin Oxime 1

Ivermectin + Pyrantel Pamoate + Praziquantel 1

Carprofen 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for NT - endocardiosis (#1785 of 2,481 by report volume); death-coded 97.8%. PlainBreed reaction plate · death-coded share stamp 97.8% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →